Home-Brewed Drugs and the Drug Development Process

Drug Development

Published June 6, 2017

Presented by the UB Clinical and Translational Science Institute Drug Development Core

Case studies in drug discovery and pre-clinical development
Opportunities to become familiar with GLP and pre-clinical drug development programs
Regulatory compliance leading to IND application
Strategies for translation to Phase I study design

Who: UB CTSI Investigators with drug discovery and drug development research programs

Where: Roswell Park Cancer Institute, Zebro Conference Room

When: Monthly, 4 – 5 p.m., first Tuesday of each month (except July, second Tuesday)

Schedule:

Date Presenter(s) Topic
6/6/17 Andrei Gudkov, PhD, DSc NAMPT Inhibitor OT-82 targeting energy metabolism in hematologic malignancies
7/11/17 Katerina Gurova, MD, PhD
Joseph Skitzki, MD
Curaxins - Novel epigenetic anticancer drug
8/1/17 Ravindra Pandey, PhD
Sandra Gollnick, PhD
New drug development perspectives in PDT
9/5/17 Lyudmila Burdelya, PhD
Vadim Krivokrysenko, PhD
Entolimod as a dual use oncology biodefense drug
10/3/17 Robert Fenstermaker, MD Anti-GBM vaccine